MECHANISMS UNDERLYING NEBIVOLOL‐INDUCED ENDOTHELIAL NITRIC OXIDE SYNTHASE ACTIVATION IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical and Experimental Pharmacology and Physiology

• Publication date

  2006-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1440-1681.2006.04424.xPMID 16895546
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endothelial cell dysfunction: the syndrome in making.

  2005cited by this paper
• Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation

  2005cited by this paper
• Endothelial β3-Adrenoreceptors Mediate Nitric Oxide–Dependent Vasorelaxation of Coronary Microvessels in Response to the Third-Generation β-Blocker Nebivolol

  2005cited by this paper
• Endothelial Function: Cardiac Events

  2005cited by this paper
• Estrogen Receptor-Mediated Vascular Responsiveness to Nebivolol: A Novel Endothelium-Related Mechanism of Therapeutic Vasorelaxation

  2004cited by this paper
• Third-Generation &bgr;-Blockers Stimulate Nitric Oxide Release From Endothelial Cells Through ATP Efflux: A Novel Mechanism for Antihypertensive Action

  2003cited by this paper
• Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase.

  2003cited by this paper
• Nebivolol Prevents Vascular NOS III Uncoupling in Experimental Hyperlipidemia and Inhibits NADPH Oxidase Activity in Inflammatory Cells

  2003cited by this paper
• Nebivolol: a selective beta(1)-adrenergic receptor antagonist that relaxes vascular smooth muscle by nitric oxide- and cyclic GMP-dependent mechanisms.

  2002cited by this paper
• Phosphorylation of Thr495 Regulates Ca2+/Calmodulin-Dependent Endothelial Nitric Oxide Synthase Activity

  2001cited by this paper
• Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity.

  2001cited by this paper
• Nebivolol: Endothelium‐Mediated Vasodilating Effect

  2001cited by this paper
• Ischemia increases detectable endothelial nitric oxide synthase in rat and human myocardium.

  2001cited by this paper
• Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium

  2001cited by this paper
• Nebivolol Induces Calcium‐Independent Signaling in Endothelial Cells by a Possible &bgr;‐Adrenergic Pathway

  2001influential reference
• Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production.

  2000cited by this paper
• Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

  1999cited by this paper
• Pharmacology of nebivolol.

  1998cited by this paper
• Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins.

  1998influential reference
• Beta-Blocking Drugs and Coronary Heart Disease

  1997cited by this paper
• Endothelial dysfunction: clinical implications.

  1997cited by this paper
• Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes.

  1996cited by this paper
• Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism.

  1995cited by this paper
• Nitric oxide mediated venodilator effects of nebivolol.

  1994cited by this paper
• Nebivolol Induces Endothelium Dependent Relaxatíons of Canine Coronary Arteries

  1991influential reference

• Targeting fibrosis and steatosis: Nebivolol multi-pathway modulator ameliorates experimental non-alcoholic steatohepatitis in rats through AMPK/mTOR and TGF-β1/α-SMA pathways.

  2025cites this paper
• Therapeutic Potential of the β3-Adrenergic Receptor and Its Ligands in Cardiovascular Diseases

  2025cites this paper
• Systematic analysis of molecules regulating nitric oxide (NO) metabolism and vascular endothelium condition

  2025cites this paper
• Age and sex mediated effects of estrogen and Β3-adrenergic receptor on cardiovascular pathophysiology.

  2024cites this paper
• Fetoplacental vascular effects of maternal adrenergic antihypertensive and cardioprotective medications in pregnancy

  2023cites this paper
• Protective Effect of Nebivolol against Oxidative Stress Induced by Aristolochic Acids in Endothelial Cells

  2022cites this paper
• The impact of nebivolol, carvedilol and propranolol on pulmonary microhemodynamics in case of experimental pulmonary thromboembolism in rabbits

  2022cites this paper
• Contrast induced acute kidney injury and the role of beta-blockers in its prevention.

  2019cites this paper
• Protective effect of nebivolol against target organ damage in hypertension

  2018cites this paper
• Nebivolol prevents vascular oxidative stress and hypertension in rats chronically treated with ethanol.

  2018cites this paper
• Nebivolol alleviates aortic remodeling through eNOS upregulation and inhibition of oxidative stress in l-NAME-induced hypertensive rats

  2017cites this paper
• What is the Real Efficacy of Beta-Blockers for the Treatment of Essential Hypertension?

  2017cites this paper
• Effects of Racemic Nebivolol and Its Stereoisomers on Rat Aortic Segments in Two Age Groups

  2016cites this paper
• Enhanced endothelium-dependent relaxation of rat pulmonary artery following β-adrenergic overstimulation: involvement of the NO/cGMP/VASP pathway.

  2015cites this paper
• ET-1 System Activity, Cardiovascular Disease Risk Factors and Pharmacologic Intervention

  2015cites this paper
• Is Nebivolol Really Effective in Preventing Contrast Induced Nephropathy?

  2015cites this paper
• Nebivolol, But Not Metoprolol, Lowers Blood Pressure in Nitric Oxide–Sensitive Human Hypertension

  2014cites this paper
• The Nebivolol action on vascular tone is dependent on actin cytoskeleton polymerization and Rho-A activity into ECs and SMCs

  2014cites this paper
• Stimulation of Platelet Nitric Oxide Production by Nebivolol Prevents Thrombosis

  2014cites this paper
• Beta blockers, nitric oxide, and cardiovascular disease.

  2013cites this paper
• Effects of Nebivolol on Aortic Compliance in Patients With Diabetes and Maximal Renin Angiotensin System Blockade: The EFFORT Study

  2013cites this paper
• Investigation of finger reflectance photoplethysmography in volunteers undergoing a local sympathetic stimulation

  2013cites this paper
• Nebivolol induced vasodilation of renal afferent arterioles involves 1 β 3 adrenergic receptor and nitric oxide synthase activation

  2012cites this paper
• Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation.

  2012cites this paper
• Metabolic Profile of Nebivolol, a β-Adrenoceptor Antagonist with Unique Characteristics

  2012cites this paper
• Nebiwolol — unikalny b-adrenolityk w praktyce klinicznej Nebivolol — unique b-adrenolytic in clinical practice

  2011cites this paper
• Chapter 46 – Antagonism of the Sympathetic Nervous System in Heart Failure

  2011cites this paper
• β‐Blockade: Benefits Beyond Blood Pressure Reduction?

  2011cites this paper
• Nebivolol has protective effect against endothelial and ileal dysfunction due to I/R.

  2011cites this paper
• THE EFFECT OF 17ß-ESTRADIOL ON THE CONTRACTION OF ISOLATED FRESH VENTRICULAR MYOCYTES OF GUINEA PIG -

  2011cites this paper
• Signaling in the Endothelium

  2011cites this paper
• Pathogenesis of hypertension: interactions among sodium, potassium, and aldosterone.

  2010cites this paper
• The effect of nebivolol on the production of nitric oxide induced by bacterial lipopolysaccharide and peptidoglycan in mice

  2010cites this paper
• Does nebivolol influence serum concentrations of proinflammatory cytokines in hypertensive (SHR) and normotensive (WKY) rats?

  2010cites this paper
• The effects of beta-blockers on endothelial nitric oxide synthase immunoreactivity in the rat corpus cavernosum.

  2010cites this paper
• Nebivolol Lowers Blood Pressure and Increases Weight Loss in Patients With Hypertension and Diabetes in Regard to Age

  2010cites this paper
• Nebivolol: the somewhat-different beta-adrenergic receptor blocker.

  2009cites this paper
• Nitric oxide mechanisms of nebivolol

  2009cites this paper
• Neither K + Channels Nor PI3K/Akt Mediates the Vasodilative Effect of Nebivolol on Different Types of Rat Arteries

  2009cites this paper
• Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta

  2009cites this paper
• Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations

  2009cites this paper
• Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study

  2009cites this paper
• RESEARCH PAPER Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta

  2009cites this paper
• How steroid hormones act on the endothelium—insights by atomic force microscopy

  2008cites this paper
• Effects of the systemic beta-adrenoceptor antagonist nebivolol on ocular hemodynamics in glaucoma patients.

  2008cites this paper
• Estrogene und Endothelfunktion

  2008cites this paper
• Signalling transduction pathways implicated in Nebivolol-induced NO production in endothelial cells

  2008cites this paper
• Protective effects of nebivolol on oxygen free radical-induced vasoconstrictions in vitro.

  2008cites this paper
• Effect of β-Blockers on Endothelial Function During Biological Aging: A Nanotechnological Approach

  2008cites this paper
• Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.

  2008cites this paper
• Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.

  2008cites this paper
• Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.

  2008cites this paper
• Evidence for an estradiol-agonistic action of nebivolol in spontaneously hypertensive rats

  2007cites this paper
• Effect of DL-nebivolol, its enantiomers and metabolites on the intracellular production of superoxide and nitric oxide in human endothelial cells.

  2007cites this paper
• The Effect of Nebivolol and Atenolol on Renal and Systemic Haemodynamics in Hypertensive Patients

  2007cites this paper
• Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.

  2007cites this paper
• Nebivolol Induces a Hyperpolarizing Effect on Smooth Muscle Cells in the Mouse Renal Artery by Activation of Beta-2-Adrenoceptors

  2007cites this paper
• Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics.

  2007cites this paper
• Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity.

  2007cites this paper
• Blood Pressure-Lowering Effect of Nebivolol in Hypertensive Patients with Type 2 Diabetes Mellitus

  2007cites this paper
• Nebivolol The Somewhat-Different (cid:1) -Adrenergic Receptor Blocker

  year unknowncites this paper